To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, and to identify novel targets for therapeutic interventions. In particular:
* To establish a central pancreatic cancer specimen repository to serve as a resource for current and future scientific studies. * To utilize the PCRT clinical data base to perform clinicopathologic correlation with the results of those studies. * To test new hypotheses as they emerge.
Study Type
OBSERVATIONAL
Enrollment
690
To collect serum and DNA samples from subjects
Scottsdale Healthcare
Scottsdale, Arizona, United States
University of Arizona/Arizona Cancer Center
Tucson, Arizona, United States
UCLA Medical Center
Los Angeles, California, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
RUSH University Medical Center
Chicago, Illinois, United States
Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins
Baltimore, Maryland, United States
Abbott Northwestern Hospital/Virginia Piper Cancer Institute
Minneapolis, Minnesota, United States
University of New Mexico
Albuquerque, New Mexico, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
South Texas Oncology and Hematology
San Antonio, Texas, United States
University Hospital (12 De Octubre)
Madrid, Spain